Prevalence of Isospora belli and Cryptosporidium parvum Infections among HIV Sero-positive Patients in Asella Hospital, Central Ethiopia
DOI:
https://doi.org/10.37591/rrjoi.v4i1.1210Abstract
Isospora belli and Cryptosporidium parvum are among the well-defined intracellular, spore-forming, coccidian opportunistic intestinal parasites that cause chronic or acute diarrhea and other life-threatening symptoms in HIV/AIDS patients particularly those with low CD4 count. Therefore, the aim of this study was to determine the prevalence of I. belli and C. parvum among HIV/AIDS sero-positive patients. A hospital based cross-sectional study was conducted at Asella Hospital from January to March, 2013. Stool samples were aseptically collected from 384 study subjects using stool cup and examined in Asella Hospital medical laboratory. The stool samples were examined using direct wet mount techniques and modified Ziehl-Neelsen method. The overall prevalence of I. belli and C. parvum infections was 10.4 and 17.7%, respectively. The prevalence of I. belli infection among males and females was 3.9 and 6.5%, respectively; while the prevalence of C. parvum infection was 7.3 and 10.4%, among males and females respectively. The prevalence of OIPP infections between both sexes, among all age groups was not statically significant (P = 0.608 and P = 0.406 for I. belli and C. parvum, respectively). Lower CD4 counts (< 200 cells/μL) (P = 0.000), being pre-ART (P = 0.001), diarrheal manifestations (P = 0.002), using unprotected water sources (P = 0.037) and absence of latrine facilities (P = 0.040) were the significant risk factors strongly associated with contracting C. parvum and I. belli infections. Therefore, public health measures and adherence to ART should be strengthened to improve the quality of life of these patients.
Keywords: ART, C. parvum, HAART, HIV/AIDS, I. belli, prevalence, risk-factors
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |